Alkermes (ALKS) Cash from Investing Activities (2010 - 2026)

Alkermes (ALKS) reported Cash from Investing Activities of -$2.1 billion for Q1 2026, down 22919.16% year-over-year from N/an in Q1 2025, and down 744.34% quarter-over-quarter from $322.3 million in Q4 2025.

Alkermes (ALKS) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Cash from Investing Activities data on file, last reported at -$2.1 billion in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$2.1 billion, down 22919.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.8 billion (down 2776.24% YoY), and the FY2025 annual result was $295.5 million, up 365.48% from the prior year.
  • Cash from Investing Activities declined to -$2.1 billion in Q1 2026 per ALKS's latest filing, from $322.3 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $322.3 million in Q4 2025 and troughed at -$2.1 billion in Q1 2026.
  • A 5-year average of -$112.0 million and a median of -$13.9 million in 2024 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 3838.54% in 2022, then tumbled 22919.16% in 2026.
  • A 5-year view of Cash from Investing Activities shows it stood at $27.7 million in 2022, then sank by 175.64% to -$21.0 million in 2023, then surged by 33.87% to -$13.9 million in 2024, then surged by 2423.21% to $322.3 million in 2025, then slumped by 744.34% to -$2.1 billion in 2026.
  • Business Quant data shows ALKS's Cash from Investing Activities at -$2.1 billion in Q1 2026, $322.3 million in Q4 2025, and -$6.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn -2.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.08 Bn
Mar 31, 2026 -2.08 Bn
Dec 31, 2025 322.35 Mn
Dec 31, 2025 322.35 Mn
Sep 30, 2025 -6.74 Mn
Sep 30, 2025 -6.74 Mn
Jun 30, 2025 -29.21 Mn
Jun 30, 2025 -29.21 Mn
Mar 31, 2025 9.10 Mn
Mar 31, 2025 9.10 Mn
Dec 31, 2024 -13.88 Mn
Dec 31, 2024 -13.88 Mn
Sep 30, 2024 -109.33 Mn
Sep 30, 2024 -109.33 Mn
Jun 30, 2024 51.85 Mn
Jun 30, 2024 51.85 Mn
Mar 31, 2024 -39.95 Mn
Mar 31, 2024 -39.95 Mn
Dec 31, 2023 -20.98 Mn
Dec 31, 2023 -20.98 Mn